// App-Quantinova.ai

572 : Treatment outcome and prognostic factors in male patients with stage IV breast cancer: A population-based study.

Researchers

Presenter

  • Ying Huang

Principal Investigators

  • Wei Chen

  • Sean Szeja

  • Sandra S. Hatch

  • Andrew M Farach

  • Darlene Miltenburg

  • E. Brian Butler

  • Bin S. Teh

Medical Centers

  • State Key Laboratory of Oncology in South China, Guangzhou, China

  • Department of General Surgery, Guangdong General Hospital, Guangzhou, China

  • UTMB Galveston, Galveston, TX

  • UTMB, Galveston, TX

  • Houston Methodist Hospital, Houston, TX

  • Texas Women's Comprehensive Breast Center, Houston, TX

  • The Methodist Hospital, Houston, TX

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved